$49.3 M

IMI Mkt cap, 14-Dec-2018

$7.9 M

Intermolecular Revenue Q3, 2018
Intermolecular Gross profit (Q3, 2018)5.8 M
Intermolecular Gross profit margin (Q3, 2018), %73.8%
Intermolecular Net income (Q3, 2018)-686 K
Intermolecular EBIT (Q3, 2018)-932 K
Intermolecular Cash, 30-Sep-20186.9 M

Intermolecular Revenue

Intermolecular revenue was $47.30 m in FY, 2016 which is a 4.4% year over year increase from the previous period.

Embed Graph

Intermolecular Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4m47.7m45.3m47.3m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5m24.7m19.3m15.8m

Gross profit

34.9m23.0m26.0m31.5m

Gross profit Margin, %

52%48%57%67%

Sales and marketing expense

6.5m5.9m7.4m

R&D expense

24.5m28.6m28.1m

General and administrative expense

12.0m12.3m10.7m

Operating expense total

43.0m46.7m46.2m

EBIT

(8.0m)(21.0m)(20.7m)(15.9m)

EBIT margin, %

(12%)(44%)(46%)(34%)

Interest expense

830.0k682.0k267.0k173.0k

Interest income

173.0k

Pre tax profit

(8.8m)(21.8m)(21.0m)(15.4m)

Income tax expense

17.0k7.0k8.0k7.0k

Net Income

(8.8m)(21.8m)(21.0m)(15.4m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

17.7m15.9m9.9m10.9m9.8m11.0m11.5m14.5m11.7m10.6m9.9m8.1m8.6m9.7m9.8m7.9m

Cost of goods sold

9.1m6.6m5.6m6.2m5.5m4.6m5.0m4.8m4.1m3.5m3.0m2.5m2.9m3.4m2.9m2.1m

Gross profit

8.7m9.3m4.3m4.7m4.4m6.4m6.5m9.7m7.6m7.1m7.0m5.5m5.7m6.3m6.9m5.8m

Gross profit Margin, %

49%59%43%43%44%58%56%67%65%67%70%69%67%65%71%74%

Sales and marketing expense

1.5m1.6m1.4m1.3m1.3m1.6m1.6m1.9m2.1m1.8m1.5m931.0k874.0k796.0k858.0k692.0k

R&D expense

6.1m7.0m6.2m5.0m6.5m7.2m7.4m6.9m6.9m8.5m7.1m5.4m4.8m4.0m4.1m4.5m

General and administrative expense

3.0m3.3m3.1m3.1m3.4m3.2m3.2m2.6m2.7m2.7m3.0m2.2m2.0m2.3m1.7m1.6m

Operating expense total

10.7m13.0m11.0m9.5m11.2m11.9m12.2m11.4m11.7m14.0m12.9m8.5m7.7m7.1m6.7m6.7m

EBIT

(2.0m)(3.6m)(6.7m)(4.8m)(6.9m)(5.6m)(5.8m)(1.7m)(4.1m)(6.9m)(6.0m)(3.0m)(2.0m)(815.0k)281.0k(932.0k)

EBIT margin, %

(11%)(23%)(67%)(44%)(70%)(51%)(50%)(12%)(35%)(65%)(60%)(37%)(23%)(8%)3%(12%)

Interest expense

168.0k194.0k179.0k159.0k134.0k121.0k52.0k32.0k40.0k51.0k55.0k58.0k70.0k106.0k140.0k168.0k

Interest income

32.0k40.0k51.0k55.0k58.0k70.0k106.0k140.0k168.0k

Pre tax profit

(2.1m)(3.8m)(6.9m)(5.0m)(7.0m)(5.7m)(5.8m)(1.7m)(4.0m)(6.8m)(5.8m)(2.9m)(1.8m)(622.0k)496.0k(686.0k)

Income tax expense

26.0k4.0k2.0k1.0k3.0k2.0k2.0k3.0k1.0k3.0k800.01.0k800.0800.0

Net Income

(2.2m)(3.9m)(6.9m)(5.0m)(7.0m)(5.7m)(5.8m)(1.7m)(4.0m)(6.8m)(5.8m)(2.9m)(1.8m)(623.0k)496.0k(686.0k)

Intermolecular Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

72.1m21.8m11.7m5.8m6.1m

Accounts Receivable

Inventories

2.2m1.8m1.6m1.4m

Current Assets

81.4m72.2m43.1m32.3m30.7m

PP&E

28.5m19.1m15.7m11.0m5.9m

Total Assets

124.5m105.4m69.7m53.2m44.3m

Accounts Payable

2.2m862.0k848.0k309.0k928.0k

Short-term debt

2.0m

Current Liabilities

14.0m10.1m10.2m5.0m5.3m

Long-term debt

Total Debt

2.0m

Total Liabilities

39.6m13.6m8.2m8.2m

Additional Paid-in Capital

194.9m202.1m209.0m213.3m214.8m

Retained Earnings

(110.1m)(131.9m)(152.9m)(168.3m)(178.7m)

Total Equity

56.1m45.0m36.1m

Financial Leverage

1.2 x1.2 x1.2 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

74.3m72.3m41.8m22.1m25.6m14.4m3.3m17.1m16.4m9.7m7.6m6.5m9.9m4.4m4.3m6.9m

Accounts Receivable

2.8m3.5m4.2m1.9m3.3m

Inventories

7.5m7.3m7.4m

Current Assets

87.8m79.3m76.0m74.0m68.9m66.6m43.5m35.9m37.9m34.5m32.6m25.5m29.2m32.4m32.7m34.9m

PP&E

27.4m26.7m24.5m21.7m18.0m16.5m16.1m15.4m14.4m12.0m9.8m8.6m7.1m4.9m4.2m3.5m

Total Assets

127.8m122.0m116.2m111.4m100.4m96.2m71.6m66.6m64.0m57.1m50.0m46.5m45.4m43.2m43.9m43.9m

Accounts Payable

3.8m615.0k1.1m221.0k617.0k1.1m1.8m224.0k786.0k327.0k746.0k1.0m1.0m399.0k145.0k752.0k

Short-term debt

2.0m2.0m2.0m2.0m

Current Liabilities

40.3m11.4m11.5m10.4m10.4m10.6m10.5m7.0m7.5m6.5m7.0m6.1m6.6m4.1m4.0m4.6m

Total Debt

2.0m2.0m2.0m2.0m

Total Liabilities

40.6m38.6m38.1m36.6m34.7m34.4m14.2m10.3m10.8m9.8m10.2m9.2m9.7m7.0m6.8m7.3m

Additional Paid-in Capital

192.8m197.3m198.9m200.6m204.6m206.4m207.8m210.8m211.7m212.6m214.0m214.3m214.5m215.1m215.4m215.6m

Retained Earnings

(105.7m)(114.0m)(120.8m)(125.8m)(138.9m)(144.6m)(150.4m)(154.6m)(158.6m)(165.3m)(174.2m)(177.0m)(178.9m)(178.9m)(178.4m)(179.1m)

Total Equity

65.7m61.8m57.4m56.3m53.2m47.3m39.8m37.3m35.7m36.2m37.1m36.6m

Financial Leverage

1.5 x1.6 x1.2 x1.2 x1.2 x1.2 x1.3 x1.2 x1.3 x1.2 x1.2 x1.2 x

Intermolecular Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(8.8m)(21.8m)(21.0m)(15.4m)(10.4m)

Depreciation and Amortization

9.4m10.9m10.7m

Accounts Receivable

1.3m1.7m(793.0k)1.1m(456.0k)

Inventories

(1.3m)1.6m(319.0k)

Accounts Payable

747.0k(635.0k)(24.0k)(493.0k)592.0k

Cash From Operating Activities

7.8m(1.8m)(4.8m)(5.4m)(873.0k)

Purchases of PP&E

(13.5m)(2.8m)(1.5m)(2.4m)(777.0k)

Cash From Investing Activities

(15.1m)(47.7m)16.6m(1.2m)1.2m

Cash From Financing Activities

1.1m(810.0k)(21.8m)701.0k(6.0k)

Interest Paid

790.0k666.0k652.0k9.0k6.0k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(2.2m)(3.9m)(10.7m)(15.7m)(7.0m)(12.7m)(5.8m)(1.7m)(4.0m)(12.4m)(5.8m)(8.7m)(10.5m)(623.0k)(127.0k)(814.0k)

Depreciation and Amortization

2.5m5.2m2.5m5.2m2.0m

Accounts Receivable

2.1m2.4m770.0k425.0k(735.0k)(1.4m)2.5m2.2m1.6m1.8m4.1m2.7m

Inventories

(711.0k)(497.0k)50.0k445.0k585.0k

Accounts Payable

(833.0k)(492.0k)(1.2m)(284.0k)144.0k1.8m(655.0k)786.0k(453.0k)746.0k743.0k688.0k(554.0k)(750.0k)(304.0k)

Cash From Operating Activities

2.0m659.0k(1.6m)(1.8m)(4.0m)(2.5m)(1.7m)(1.6m)(1.2m)1.7m5.9m5.0m

Purchases of PP&E

(1.5m)(2.0m)(2.6m)(927.0k)(1.3m)(1.4m)(2.1m)(521.0k)(705.0k)(194.0k)(489.0k)(620.0k)

Cash From Investing Activities

(2.1m)(31.1m)(48.1m)5.7m(3.0m)7.3m(988.0k)2.3m5.3m(3.4m)(7.8m)(4.4m)

Cash From Financing Activities

339.0k163.0k(325.0k)37.0k(395.0k)693.0k707.0k(11.0k)(13.0k)17.0k172.0k187.0k

Interest Paid

73.0k272.0k471.0k191.0k374.0k5.0k5.0k6.0k

Intermolecular Ratios

USDY, 2018

Financial Leverage

1.2 x
Report incorrect company information

Intermolecular Employee Rating

3.137 votes
Culture & Values
3.1
Work/Life Balance
3.1
Senior Management
2.4
Salary & Benefits
3.0
Career Opportunities
2.8
Source